Skip to main content

Nasdaq Markets

OKTA Crosses Above Average Analyst Target

6 years 7 months ago
In recent trading, shares of Okta Inc (Symbol: OKTA) have crossed above the average analyst 12-month target price of $136.40, changing hands for $137.27/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuati
BNK Invest

TRNO Crosses Above Average Analyst Target

6 years 7 months ago
In recent trading, shares of Terreno Realty Corp (Symbol: TRNO) have crossed above the average analyst 12-month target price of $59.33, changing hands for $59.57/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade o
BNK Invest

BURL Crosses Above Average Analyst Target

6 years 7 months ago
In recent trading, shares of Burlington Stores Inc (Symbol: BURL) have crossed above the average analyst 12-month target price of $232.76, changing hands for $243.45/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgra
BNK Invest

Disney+ Blowout Numbers Don't Mean Anything -- Yet

6 years 7 months ago
Disney (NYSE: DIS) reported robust subscriber numbers for its Disney+ streaming service when first-quarter earnings came out the other day, but the totals were surprisingly strong even with the heightened expectations.
The Motley Fool

Is Siemens (ADR) Stock a Buy?

6 years 7 months ago
The case for buying stock in the German industrial giant is based on two pillars. First is its hefty dividend -- current yield is around 3.6%. Second is that the diversification in its mix of businesses should ensure its earnings and dividend can grow throughout the economic cyc
The Motley Fool

Why Claiming Social Security Is Really Just a Gamble

6 years 7 months ago
One of the most difficult retirement decisions you'll have to make is choosing when to file for Social Security. Though your benefits are calculated based on your lifetime earnings, you're not entitled to your full monthly benefit until you reach full retirement age, or FRA. Her
The Motley Fool

AbbVie Is a Dividend Growth Stock at a Bargain Price

6 years 7 months ago
AbbVie (NYSE: ABBV) reported fourth-quarter earnings on Friday that were above consensus and the company raised its guidance for 2020. The results suggested that there was life after Humira, its mainstay immunology product, which is the world's best-selling drug.
The Motley Fool
Checked
9 minutes 32 seconds ago
This feed is responsible for generating the rss feed related to the topic Markets
Subscribe to Nasdaq Markets feed